URBN
48
-6
CL
54
3
D
40
2
LUV
45
-2
UNH
57
-2
IPG
34
-9
T
48
3
SNA
70
-5
HPE
44
-2
CINF
53
3
NWS
75
-4
MO
60
-2
EXC
54
3
INTU
58
-3
GIS
22
-4
DHR
32
-6
DNB
74
-6
CMI
64
-3
ICE
59
-3
HRL
35
-3
URBN
48
-6
CL
54
3
D
40
2
LUV
45
-2
UNH
57
-2
IPG
34
-9
T
48
3
SNA
70
-5
HPE
44
-2
CINF
53
3
NWS
75
-4
MO
60
-2
EXC
54
3
INTU
58
-3
GIS
22
-4
DHR
32
-6
DNB
74
-6
CMI
64
-3
ICE
59
-3
HRL
35
-3
Financhill
Back

Energy Services of America Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
70

ESOA
Energy Services of America

Last Price:
13.82
Seasonality Move:
15.38%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Buy
70
Energy Services of America (ESOA) is a Buy

Is Energy Services of America a Buy, Sell or Hold?

  • The current Energy Services of America [ESOA] share price is $13.85. The Score for ESOA is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
  • ESOA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ESOA Stock Price Chart

What is Energy Services of America's stock price today?

  • The Energy Services of America share price today is $13.85
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ESOA is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

ESOA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.03 Buy
Relative Strength Index (14 RSI): 71.89 Buy
Chaikin Money Flow: -168849 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.3 - 13.1) Buy
Bollinger Bands (100): (7.47 - 11.29) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

ESOA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.52 Buy
20-day SMA: 12.04 Buy
50-day SMA: 10.75 Buy
200-day SMA: 8.45 Buy
8-day EMA: 13.47 Buy
20-day EMA: 12.39 Buy
50-day EMA: 11.05 Buy
200-day EMA: 8.54 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Energy Services of America Earnings Growth & ESOA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Energy Services of America Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):